Recent Trends in Treatment of Multidrug Resistant-Tuberculosis-A Review

Y. Himasree, K. Sukanya, K. Bhavyasri, K. Amrutha, Kothandam Hariprasath
{"title":"Recent Trends in Treatment of Multidrug Resistant-Tuberculosis-A Review","authors":"Y. Himasree, K. Sukanya, K. Bhavyasri, K. Amrutha, Kothandam Hariprasath","doi":"10.4172/2161-1068.1000250","DOIUrl":null,"url":null,"abstract":"Drug resistance is reduction in effectiveness of an anti-microbial agents used in inhibiting the microorganisms or curing a disease. Mycobacterium tuberculosis is responsible for causing tuberculosis can acquire multiple drug resistance by not responding to Isoniazid and Rifampicin the two most powerful anti-TB agents. The complications of drug resistance in TB elevates due to some of the risk factors like inadequate treatment compliance, noncompliance of the patients to the treatment. \nProper diagnosis of the disease and switching to modified drug therapy may improve the treatment outcome. The drug treatment involves usage of combination of drugs Isoniazid, Rifampicin, Ethambutol along with other antimicrobial agents, and nutritional therapy, immunotherapy. In this review we discussed about the occurrence, treatment of multi drug resistance tuberculosis along with drugs under trials and nutritional requirements.","PeriodicalId":74235,"journal":{"name":"Mycobacterial diseases : tuberculosis & leprosy","volume":"7 1","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2017-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2161-1068.1000250","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mycobacterial diseases : tuberculosis & leprosy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2161-1068.1000250","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Drug resistance is reduction in effectiveness of an anti-microbial agents used in inhibiting the microorganisms or curing a disease. Mycobacterium tuberculosis is responsible for causing tuberculosis can acquire multiple drug resistance by not responding to Isoniazid and Rifampicin the two most powerful anti-TB agents. The complications of drug resistance in TB elevates due to some of the risk factors like inadequate treatment compliance, noncompliance of the patients to the treatment. Proper diagnosis of the disease and switching to modified drug therapy may improve the treatment outcome. The drug treatment involves usage of combination of drugs Isoniazid, Rifampicin, Ethambutol along with other antimicrobial agents, and nutritional therapy, immunotherapy. In this review we discussed about the occurrence, treatment of multi drug resistance tuberculosis along with drugs under trials and nutritional requirements.
耐多药结核病治疗的最新趋势综述
耐药性是用于抑制微生物或治疗疾病的抗微生物剂的有效性降低。结核分枝杆菌对异烟肼和利福平这两种最有效的抗结核药物无反应,可获得多重耐药。由于一些风险因素,如治疗依从性不足,患者不遵守治疗,结核病耐药并发症会增加。正确诊断疾病并改用改良药物治疗可改善治疗结果。药物治疗包括异烟肼、利福平、乙胺丁醇与其他抗菌剂联合使用,以及营养疗法、免疫疗法。本文综述了耐多药结核病的发生、治疗、试验药物和营养需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信